Close Menu

NEW YORK – Agilent Technologies announced on Tuesday that it plans to acquire precision oncology firm Resolution Bioscience for up to $695 million in cash and milestone payments. 

Under the deal, expected to close in April, Agilent will pay $550 million in cash on closing and up to an additional $145 million based on future performance milestones. 

To read the full story....

...and receive Weekly News bulletins.

Already have a Precision Oncology News or 360Dx or GenomeWeb account?
Login Now.

Don't have a Precision Oncology News or 360Dx or GenomeWeb account?
Register for Free.